Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Better models and evaluation methods for alopecia areata are needed.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

Combining OMP with cyclosporine can effectively treat severe alopecia areata in children.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Topical tacrolimus is effective and safe for treating alopecia areata.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

An 8-year-old girl had nail and hair issues that improved without specific treatment, but fungal nail infection was hard to cure.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

A man's scalp hair loss was due to a combined melanocytic nevus and alopecia areata, suggesting a possible link between the two conditions.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

Alopecia areata in infants may be more common than previously thought.

Psychological factors play a significant role in developing alopecia areata.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.